Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2021

Earnings Per Share [Abstract]

Schedule of Basic and Fully Diluted Net Loss Per Share

The “Net loss per share basic and diluted” for the respective periods indicated - is as follows:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2021			2020			2021			2020
Numerator
Net loss	$	(6,956,619	)	$	(2,021,677	)	$	(16,772,393	)	$	(5,548,873	)
Denominator
Weighted average common shares outstanding, basic and diluted		14,114,707			14,114,707			14,114,707			14,114,347
Net Loss per share
Net loss per share - basic and diluted	$	(0.49	)	$	(0.14	)	$	(1.19	)	$	(0.39	)

Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Earnings Per Share

	September 30,
	2021		2020
Lucid Diagnostics Inc. 2018 Equity Plan:
- stock options		975,942		975,942
- unvested restricted stock awards		1,813,135		—
Stock options not granted under a plan		423,300		423,300
Total		3,212,377		1,399,242